GlassScriptPhysician profile
Yan Katsnelson
NPI 1285672840
$8,534.53
in general payments reported to CMS, 2019-2025
6 companies · $4,177 in 2025
The $4,177 reported for 2025 was more than what 80% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,477 · 2021: $1,045 · 2022: $712 · 2024: $124 · 2025: $4,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,177 · Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,176.55 |
| Food and Beverage | $124.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $4,176.55 | 2025 | |
| Philips North America LLC | $2,300.20 | 2019 | |
| Boston Scientific Corporation | $1,151.72 | 2019-2022 | |
| Canon Medical Systems USA, INC. | $753.60 | 2021 | |
| Ge Healthcare | $124.43 | 2024 | |
| Biocompatibles, INC. | $28.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Katsnelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.